Novo Nordisk A/S
Novo Nordisk A/S (NVO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVO · as of Jun 8, 2026
Key Statistics
Explore Novo Nordisk A/S Data
nvo stock data · financialsAbout Novo Nordisk A/S
Novo Nordisk A/S together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, …
what is novo nordisk a/s · nvo stock overview · novo nordisk a/s company profile · who is novo nordisk a/s ceo · nvo NYSE · novo nordisk a/s headquarters · novo nordisk a/s business segments
About Stock Overview & Key Data
Novo Nordisk A/S (NVO) is a Healthcare company in the Biotechnology industry, listed on NYSE since Apr 30, 1981. As of the latest trading session, NVO stock price is $42.96, with a market capitalization of $190.9B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Novo Nordisk A/S (NVO) stock price is $42.96. The stock is traded on NYSE under the ticker symbol NVO. The 52-week range is $35.12 – $81.44.